Infections in the solid-organ transplant recipients

Keywords: solid-organ, transplant recipient, infections, risk factors, timeline, prevention.

Abstract

The advancement in the field of transplant has led to the increasing number of solid-organ transplant recipients (SOTRs). This success leads to novel confronts in communicable infections, which are compound by the emergence of newly contagious and antimicrobial drugs resistant microorganisms. The prevention of infections is a cornerstone of any modern solid organ transplantation program. Understanding the fundamentals of these infections with early detection is crucial for improving the outcomes of such patients and lowers the probable extra complications.  The probability of critical infections in SOTRs is established by relations between the patient’s epidemiological exposures and the net condition of immune repression. A timeline was formed to build up a discrepancy diagnosis of infection in SORTs. The improvement in screening, the investigations including imaging and molecular techniques and prophylactic intervention protocols, has made it promising to limit the penalty of infections and act towards better patient endurance. Pre-transplant screening of the prospective organ donor and recipient provides a chance to evaluate the viability and wellbeing of transplantation, to decide the prophylaxis and protective approaches developed post-transplant, to find out and entirely treat active infection in the possible recipient proceeding to transplant, to renovate the vaccination condition of the potential recipient.

Downloads

Download data is not yet available.

References

Park B, Yoon J, Choi D, et al. De novo cancer incidence after kidney and liver transplantation: Results from a nationwide population based data. Sci Rep. 9; 2019:17202.  Available from:  https://www.nature.com/articles/s41598-019-53163-9.

Kumar R, Ison MG. Opportunistic Infections in Transplant Patients. Infect Dis Clin N Am. 2019; 33:1143-1157. doi: 10.1016/j.idc.2019.05.008.

World Health Organization (WHO). International report on organ donation and transplantation activities executive summary 2019. WHO collaborating center “Global observatory on donation and transplantation”. Available from: http://www.transplant-observatory.org/.

Hart A, . JM, Skeans MA, et al. OPTN/SRTR 2016 Annual Data Report: Kidney. Am J Transplant. 2018; 18(1):18-113. doi: 10.1111/ajt.14557.

Kim WR, Lake JR, Smith JM, et al. OPTN/SRTR 2016 Annual Data Report: Liver. Am J Transplant. 2018; 18(1):172-253. doi: 10.1111/ajt.14559.

Wolfe CR, Ison MG. on behalf of the AST ID Community of Practice. Donor-derived infections: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019; 33:e13547. doi: 10.1111/ctr.13547.

Vinkenes E, Nielsen MA, Blaakaer J. Is there evidence for efficacy of human papillomavirus vaccination in solid organ transplant recipients?. Eur J Obstet Gynecol Reprod Biol X. 4 2019; 100015.  doi: 10.1016/j.eurox.2019.100015.

Cai YS, Xiao H, Zhang S, et al. Carbapenem-resistant Klebsiella pneumoniae infection causing rupture of graft artery in solid organ recipients: Case report and review of literature. Medicine (Baltimore). 2019; 98(45):e17878. doi: 10.1097/MD.0000000000017878.

Fishman JA. Infection in organ transplantation. Am J Transplant. 2017; 17: 856-879.  doi: 10.1111/ajt.14208.

Nellore A, Fishman JA. The microbiome, systemic immune function, and allotransplantation.   Clin Microbiol Rev. 2016; 29:191-199. doi: 10.1128/CMR.00063-15.

Ison MG, Nalesnik MA. An update on donor-derived disease transmission in organ transplantation. Am J Transplant. 2011;11(6):1123-1130. doi: 10.1111/j.1600-6143.2011.03493.x.

Malinis M, Boucher HW, on behalf of the AST Infectious Diseases Community of Practice. Screening of donor and candidate prior to solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019; 33:e13548. doi: 10.1111/ctr.13548.

Garzoni C, Ison MG. Uniform definitions for donor-derived infectious disease transmissions in solid organ transplantation. Transplantation. 2011; 92 (12):1297-1300.  doi: 10.1097/TP.0b013e318236cd02.

Blumberg EA, Danziger-Isakov L, Kumar D, et al. American Society of Transplantation: Infectious Disease Guidelines 3rd Edition. Am J Transplant. 2013; 13(Suppl4):1-371. Available from: https://onlinelibrary.wiley.com/toc/16006143/2013/13/s4.

Fishman JA. Editorial commentary: Immune reconstitution syndrome: How do we “tolerate” our microbiome? Clin Infect Dis. 2015; 60: 45-47. doi:  10.1093/cid/ciu717.

Avery RK, Michaels MG, on behalf of the AST ID Community of Practice. Strategies for safe living following solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019; 33:e13519. doi: 10.1111/ctr.13519.

Husain S, Camargo JF, on behalf of the AST ID Community of Practice. Invasive Aspergillosis in solid-organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33: e13544. doi: 10.1111/ctr.13544.

Restrepo A, Clark NM, on behalf of the AST ID Community of Practice. Nocardia infections in solid organ transplantation: Guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation. Clin Transplant. 2019; 33:e13509. doi: 10.1111/ctr.13509.

Baddley JW, Forrest GN, on behalf of the AST ID Community of Practice. Cryptococcosis in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019; 33:e13543. doi: 10.1111/ctr.13543.

Miller R, Assi M, on behalf of the AST ID Community of Practice. Endemic fungal infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33:e13553. doi: 10.1111/ctr.13553.

Pouch SM, Patel G, on behalf of the AST Infectious Diseases Community of Practice. Multidrug-resistant Gram-negative bacterial infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019; 33:e13594. doi: 10.1111/ctr.13594.

Pereira MR, Rana MM, on behalf of the AST ID Community of Practice. Methicillin-resistant Staphylococcus aureus in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019; 33:e13611. doi: 10.1111/ctr.13611.

Mullane KM, Dubberke ER, on behalf of the AST ID Community of Practice. Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: Guidelines from the American Society of Transplantation Community of Practice. Clin Transplant. 2019; 33:e13564. doi: 10.1111/ctr.13564.

Abbo LM, Grossi PA, on behalf of the AST ID Community of Practice. Surgical site infections: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019; 33:e13589. doi: 10.1111/ctr.13589.

Aslam S, Rotstein C, on behalf of the AST ID Community of Practice. Candida infections in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019; 33:e13623. doi: 10.1111/ctr.13623.

Helfrich M, Dorschner P, Thomas K, et al. A retrospective study to describe the epidemiology and outcomes of opportunistic infections after abdominal organ transplantation. Transpl Infect Dis. 2017; 19(3). doi: 10.1111/tid.12691.

Kang RA, Han S, Kim JM et al. Postoperative hyperglycemia may negatively impact cytomegalovirus infection in seropositive liver transplant recipients: a retrospective cohort study. Transplant International. 2020; 33: 68-75. doi: 10.1111/tri.13496.

Lee DH, Zuckerman RA, on behalf of the AST ID Community of Practice.  Herpes simplex virus infections in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33:e13526. doi: 10.1111/ctr.13526.

Pergam SA, Limaye AP, on behalf of the AST ID Community of Practice. Varicella zoster virus in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33:e13622. doi: 10.1111/ctr.13622.

Allen UD, Preiksaitis JK, on behalf of the AST ID Community of Practice. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019;33:e13652. doi: 10.1111/ctr.13652.

Madan RP, Hand J, on behalf of the AST ID Community of Practice  Human herpesvirus 6, 7, and 8 in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019;33:e13518. doi: 10.1111/ctr.13518.

Te H, Doucette K. Viral hepatitis: Guidelines by the American Society of Transplantation Infectious Disease Community of Practice. Clinical Transplantation. 2019;33:e13514. doi: 10.1111/ctr.13514.

Manuel O, Estabrook M, on behalf of the AST ID Community of Practice. RNA respiratory viral infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019; 33: e13511. doi: 10.1111/ctr.13511.

Fishman JA, Gans H, on behalf of the AST ID Community of Practice. Pneumocystis jiroveci in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019; 33:e13587. doi: 10.1111/ctr.13587.

La Hoz RM, Morris MI, on behalf of the AST I D Community of Practice. Tissue and blood protozoa including toxoplasmosis, Chagas disease, leishmaniasis, Babesia, Acanthamoeba, Balamuthia, and Naegleria in solid organ transplant recipients- Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019 a ;33:e13546. doi.10.1111/ctr.13546.

Green M, Covington S, Taranto S, et al. Donor-derived transmission events in 2013: A report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission Advisory Committee. Transplantation. 2015; 99: 282-227. doi: 10.1097/TP.0000000000000584.

Humar A, Morris M, Blumberg E, et al. Nucleic acid testing (NAT) of organ donors: is the 'best' test the right test? A consensus conference report. Am J Transplant. 2010; 10(4):889-899. doi: 10.1111/j.1600-6143.2009.02992.x.

Winston DJ, Vikram HR, Rabe IB, et al. Donor-derived West Nile virus infection in solid organ transplant recipients: report of four additional cases and review of clinical, diagnostic, and therapeutic features. Transplantation. 2014; 97(9):881-889. doi: 10.1097/TP.0000000000000024.

Dulek DE, Mueller NJ, on behalf of the AST Infectious Diseases Community of Practice. Pneumonia in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33: e13545. doi: 10.1111/ctr.13545.

Abad CLR, Razonable RR. Mycobacterium tuberculosis after solid organ transplantation: A review of more than 2000 cases. Clin Transplant. 2018; 32:e13259. doi: 10.1111/ctr.13259.

Hand J, Sigel K, Huprikar S, et al. Tuberculosis after liver transplantation in a large center in New York City: QuantiFERON® -TB Gold-based pre-transplant screening performance and active tuberculosis post-transplant. Transpl Infect Dis. 2018; 20(2):e12845. doi: 10.1111/tid.12845.

Subramanian AK,Theodoropoulos NM, on behalf of the AST ID Community of Practice. Mycobacterium tuberculosis infections in solid organ transplantation: Guidelines from the infectious diseases community of practice of the American Society of Transplantation. Clin Transplant. 2019;33:e13513. doi: 10.1111/ctr.13513.

Wolfe C, Wilk A, Tlusty S, et al. Donor-derived toxoplasmosis in solid organ transplant 2008-2015: opportunities for improvement. Am J Transplant. 2016;16 (3). Available from: https://atcmeetingabstracts.com/abstract/donor-derived-toxoplasmosis-in-solid-organ-transplant-2008-2015-opportunities-for-improvement/.

La Hoz RM, Morris MI, on behalf of the AST Infectious Diseases Community of Practice. Intestinal parasites including Cryptosporidium, Cyclospora, Giardia, and Microsporidia, Entamoeba histolytica, Strongyloides, Schistosomiasis, and Echinococcus: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33: e13618. doi: 10.1111/ctr.13618.

Blumberg EA, Rogers CC, on behalf of the AST ID Community of Practice. Solid organ transplantation in the HIV-infected patient: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019; 33:e13499. doi: 10.1111/ctr.13499.

Theodoropoulos N, Nowicki MJ, Chinchilla-Reyes C, et al. Deceased organ donor screening for human immunodeficiency virus, hepatitis B virus and hepatitis C virus: discordant serology and nucleic acid testing results. Transpl Infect Dis. 2018;20(1). doi: 10.1111/tid.12821.

Wilson MR, Zimmermann LL, Crawford ED, et al. Acute West Nile Virus meningoencephalitis diagnosed via metagenomic deep sequencing of cerebrospinal fluid in a renal transplant patient. Am J Transplant. 2017;17(3):803–808. doi: 10.1111/ajt.14058.

Anesi JA, Silveira FP, on behalf of the AST ID Community of Practice. Arenaviruses and West Nile Virus in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019; 33:e13576. doi: 10.1111/ctr.13576.

Simkins J, Anjan S, Morillas-Rodriguez Ja, et al. Screening for Zika virus in deceased organ donors in Florida. Am J Transplant. 2018;18(3):731-736. doi: 10.1111/ajt.14582.

Morris MI, Grossi P, Nogueira ML, et al. Arboviruses recommendations for solid-organ transplant recipients and donors. Transplantation. 2018; 102 (S2):S42-S51. doi: 10.1097/TP.0000000000002011.

Wagenlehner FM, Umeh O, Steenbergen J, et al. Ceftolozane-tazobactam

compared with levofloxacin in the treatment of complicated urinary-tract

infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI). Lancet. 2015; 385(9981): 1949-1956. doi: 10.1016/S0140-6736(14)62220-0.

Jacobs DM, DiTursi S, Ruh C, et al. Combination treatment with extended infusion ceftazidime/avibactam for a KPC-3-producing Klebsiella pneumonia bacteraemia in a kidney and pancreas transplant patient. Int J Antimicrob Agents. 2016; 48(2): 225-227. doi: 10.1016/j.ijantimicag.2016.06.002.

Razonable RR, Humar A. Cytomegalovirus in solid organ transplant recipients: Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33: e13512. doi: 10.1111/ctr.13512.

Danziger-Isakov L, Kumar D, On Behalf of AST ID Community of Practice. Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant. 2019; 33:e13563. doi: 10.1111/ctr.13563.

Feldman AG, Hsu EK, Mack CL. The Importance of Prioritizing Pre and Posttransplant Immunizations in an Era of Vaccine Refusal and Epidemic Outbreaks. Transplantation. 2020; 104(1):33-38. doi: 10.1097/TP.0000000000002936.

Natori Y, Shiotsuka M, Slomovic J, et al. A double-blind, randomized trial of high-dose vs standard-dose influenza vaccine in adult solid-organ transplant recipients. Clin Infect Dis. 2018; 66(11):1698-1704. doi: 10.1093/cid/cix1082.

Schillie S, Harris A, Link-Gelles R, et al. Recommendations of the advisory committee on immunization practices for use of a hepatitis B vaccine with a novel adjuvant. MMWR Morb Mortal Wkly Rep. 2018; 67(15):455-458. doi: 10.15585/mmwr.mm6715a5.

Saadi MG, El-Khashab SO, Mahmoud RMA. Renal transplantation experience in Cairo University hospitals. The Egyptian Journal of Internal Medicine. 2016, 28:116-122. Available from: https://ejim.springeropen.com/articles/10.4103/1110-7782.200967.

El Maghrabi HM, Elmowafy AY, Donia AF, et al. Treatment of Chronic Hepatitis C Infection among Egyptian Kidney Transplant Recipients: A Pilot Study. Experimental and Clinical Transplantation. 2019; 1: 62-67.   doi: 10.6002/ect.MESOT2018.L57.

Alsaid M, Elsawy E, Akl A, et al. H1n1 infection among Egyptian renal transplant recipients. Urol Nephrol Open Access J. 2016; 3(1):20-25. doi: 10.15406/unoaj.2016.03.00065.

El-Agroudy AE, Refaie AF, Moussa OM, et al. Tuberculosis in Egyptian kidney transplant recipients: Study of clinical course and outcome. J Nephrol. 2003; 16: 404-411. Available from: https://pubmed.ncbi.nlm.nih.gov/12832742/.

Bakr NI, El-Sawy E, Hamdy AF, et al. Skin infections in Egyptian renal transplant recipients. Transpl Infect Dis. 2011; 13:131-135. doi: 10.1034/j.1399-0012.2001.150106.x.

Mai I Mehrez. Liver Transplantation in Egypt. Gastro Med Res. 1(1). GMR.000503. 2017. doi: 10.31031/GMR.2017.01.000503

Saleh AM, Essam HA, Gomaa AA, et al. Impact of pre-transplant infection management on the outcome of living-donor liver transplantation in Egypt. Infection and Drug Resistance. 2019; 12:2277-2282. doi: 10.2147/IDR.S208954.

Yosry M, Abdel R, Esmat G, et al.  Recurrence of hepatitis C virus (genotype 4) infection after living-donor liver transplant in Egyptian patients. Exp Clin Transplant. 2009; 7(3):157-163. Available from: https://pubmed.ncbi.nlm.nih.gov/19715525/.

Amer KE, Marwan I. Living donor liver transplantation in Egypt. HepatoBiliary Surg Nutr. 2016; 5(2):98-106. doi: 10.3978/j.issn.2304-3881.2015.10.03.

Montasser MF, Abdelkader NA, Abdelhakam SM, et al. Bacterial infections post-living-donor liver transplantation in Egyptian hepatitis C virus-cirrhotic patients: A single center study. World J Hepatol. 2017; 9 (20): 896-904.     doi: 10.4254/wjh.v9.i20.896.

Gad EH, Alsebaey A, Lotfy M, et al. Complications and mortality after adult to adult living donor liver transplantation: A retrospective cohort study. Ann Med Surg. 2015; 4: 162-171. doi: 10.1016/j.amsu.2015.04.021.


Abstract views: 689
PDF Downloads: 17263
Published
2021-04-13
How to Cite
Said, M. E. (2021). Infections in the solid-organ transplant recipients . Ukrainian Journal of Nephrology and Dialysis, (2(70), 64-76. https://doi.org/10.31450/ukrjnd.2(70).2021.08